Methods We assessed 23 patients with the PROSTALAC implant in situ for treatment of an
infected THR for function and HRQL, using standardized outcome measures. These patients …

We report the outcome at ten to 15 years of two-stage revision for hip infection in 99 patients
using the Prostalac articulated hip spacer system. All the patients were contacted to …

Methods We identified 28 patients treated for infected THR with the PROSTALAC system, by
retrospective chart review. Preoperative and intraoperative cultures were taken to identify …

Background: The study purpose was to (1) evaluate health-related quality of life (HRQL) with
the PROSthesis of Antibiotic Loaded Acrylic Cement (PROSTALAC) in situ for infected total …

Background The purpose of this study was to compare the clinical outcomes after 2-stage
revision with those following single-stage revision in patients who developed periprosthetic …

Introduction: Very limited information is available regarding patient-reported health-related
quality of life (HRQoL) and hip function following treatment for chronic periprosthetic hip joint …

Background Patients treated for early prosthetic joint infection (PJI) with surgical
debridement, prosthesis retention and biofilm‐active antibiotics, such as rifampicin or …

Background: Two-stage exchange arthroplasty remains the standard treatment of infection at
the site of a total knee arthroplasty. The clinical and functional outcomes associated with the …

Background Periprosthetic joint infection (PJI) affects approximately 1% of patients following
total hip replacement (THR) and often results in severe physical and emotional suffering …

Background and purpose Successful treatment of prosthetic hip joint infection (PI) means
elimination of infection and restored hip function. However, functional outcome is rarely …